לויטרה 5 מג Israel - hebraisk - Ministry of Health

לויטרה 5 מג

bayer israel ltd - vardenafil as hydrochloride trihydrate - טבליות מצופות פילם - vardenafil as hydrochloride trihydrate 5 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

לויטרה 10 מג Israel - hebraisk - Ministry of Health

לויטרה 10 מג

bayer israel ltd - vardenafil as hydrochloride trihydrate - טבליות מצופות פילם - vardenafil as hydrochloride trihydrate 10 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

לויטרה 20 מג Israel - hebraisk - Ministry of Health

לויטרה 20 מג

bayer israel ltd - vardenafil as hydrochloride trihydrate - טבליות מצופות פילם - vardenafil as hydrochloride trihydrate 20 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

דואודרט Israel - hebraisk - Ministry of Health

דואודרט

glaxo smith kline (israel) ltd - dutasteride; tamsulosin hydrochloride - קפסולות - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - treatment of moderate to severe symptoms of benign prostatic hyperplasia (bph). reduction in the risk of acute urinary retention (aur) and surgery in patients with moderate to severe symptoms of bph.

פרו-קיור 5 מג Israel - hebraisk - Ministry of Health

פרו-קיור 5 מג

merck sharp & dohme israel ltd - finasteride - טבליה - finasteride 5 mg - finasteride - finasteride - for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to: reduce the risk of acute urinary retention. reduce the risk of surgery including transurethral resection of the prostate (turp)and prostatectomy. pro-cure causes regression of the enlarged prostate, improves urinary flow and improves the symptoms assocciated with bph. patients with an enlarged prostate are the appropriate candidates for therapy with pro-cure.

פרופסיה Israel - hebraisk - Ministry of Health

פרופסיה

organon pharma israel ltd., israel - finasteride - טבליות מצופות פילם - finasteride 1 mg - finasteride - finasteride - propecia is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss

טאבניק טבליות 500 מג Israel - hebraisk - Ministry of Health

טאבניק טבליות 500 מג

sanofi israel ltd - levofloxacin as hemihydrate - טבליות מצופות פילם - levofloxacin as hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity tavanic tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

מגאקסין טבליות Israel - hebraisk - Ministry of Health

מגאקסין טבליות

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

מגאקסין טבליות Israel - hebraisk - Ministry of Health

מגאקסין טבליות

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

מגאקסין IV Israel - hebraisk - Ministry of Health

מגאקסין iv

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.